These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7401966)

  • 21. The use of radioactive oxygen to study muscle function in peripheral vascular disease.
    Clyne CA; Jones T; Moss S; Ensell J
    Surg Gynecol Obstet; 1979 Aug; 149(2):225-8. PubMed ID: 462356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Utiligation of muscular tissue clearance of 133 xenon].
    Mörl H
    Vasa; 1975; 4(2):157-60. PubMed ID: 1136568
    [No Abstract]   [Full Text] [Related]  

  • 23. [Characteristics of blood-flow changes in major vessels and muscles in obliterating lesions of the vessels of the leg in diabetics].
    Tkach FS; Davydova LI; Vorpaĭ TI
    Klin Khir (1962); 1982 Jul; (7):58-9. PubMed ID: 7132096
    [No Abstract]   [Full Text] [Related]  

  • 24. Tissue clearance of 131 I after sympathectomy.
    Lukasiewicz S
    Pol Med J; 1972; 11(1):197-201. PubMed ID: 5040997
    [No Abstract]   [Full Text] [Related]  

  • 25. On the estimation of local effective perfusion pressure in patients with obliterative arterial disease by means of external compression over a Xenon-133 depot.
    Nilsén R; Dahn I; Lassen NA; Westling H
    Scand J Clin Lab Invest Suppl; 1967; 99():29-30. PubMed ID: 6056929
    [No Abstract]   [Full Text] [Related]  

  • 26. Routine use of the xenon-133 clearance method in peripheral circulation studies, with special regard to its correlation to angiography.
    Lindbjerg IF
    Scand J Clin Lab Invest Suppl; 1967; 99():123-9. PubMed ID: 6056906
    [No Abstract]   [Full Text] [Related]  

  • 27. [Muscle stimulation test. A method of evaluation of the muscle blood supply in arterial occlusion diseases of the lower extremities].
    Glatzel W; Preuss EG
    Munch Med Wochenschr; 1967 Feb; 109(6):309-14. PubMed ID: 5631727
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute effect of xanthinol nicotinate on the muscle clearance of 133Xenon.
    Szilvási I; Molnár G
    Ther Hung; 1973; 21(3-4):114-6. PubMed ID: 4806418
    [No Abstract]   [Full Text] [Related]  

  • 29. [Muscular blood flow in occlusive diseases of arteries of the lower limbs and the effect of medicinal preparations].
    Lyskova MN; Kuz'min VP; Tsypliaev VA; Bogoliubov VM
    Klin Med (Mosk); 1975 Apr; 53(4):47-50. PubMed ID: 1152370
    [No Abstract]   [Full Text] [Related]  

  • 30. Muscle blood flow measured by XE-133 clearance method and peripheral vascular diseases. Part 2. Normals and patients with peripheral vascular diseases.
    Hirai M
    Jpn Circ J; 1974 Aug; 38(8):661-6. PubMed ID: 4421741
    [No Abstract]   [Full Text] [Related]  

  • 31. Testosterone in the treatment of arterial insufficiency of the lower limbs.
    Hentzer E; Madsen PC
    Scand J Clin Lab Invest Suppl; 1967; 99():198-206. PubMed ID: 4862833
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical rheovasographic comparisons in arteriosclerosis obliterans of the lower extremities].
    Akhverdian RA; Nagapetian IO
    Zh Eksp Klin Med; 1972; 12(4):76-83. PubMed ID: 4668897
    [No Abstract]   [Full Text] [Related]  

  • 33. Measurement of the post-exercise blood flow in the calf muscle as a means of predicting the benefit of lumbar sympathectomy in obliterating arterial disease.
    Hirsjärvi E; Karppinen V
    Scand J Clin Lab Invest Suppl; 1967; 100():89. PubMed ID: 6038161
    [No Abstract]   [Full Text] [Related]  

  • 34. [Speed of propagation of the rheographic wave in the lower extremities in normal subjects, patients with arteriosclerosis obliterans and subjects with peripheral arterial sclerosis].
    Di Renzi L; Leggio F; Cassone R; Lucisano V; Gambelli G
    Riv Med Aeronaut Spaz; 1970; 33(3):307-29. PubMed ID: 5513754
    [No Abstract]   [Full Text] [Related]  

  • 35. [The volume rate of blood flow in the arteries of the lower extremities in occlusive arterial diseases].
    Alekseev PP; Sadekova AK
    Vestn Khir Im I I Grek; 1967 Nov; 98(11):21-5. PubMed ID: 5607644
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical use of Xe-133 non-ischemic work method in obliterative arterial diseases of the legs.
    Hirai M; Shionoya S
    Jpn Circ J; 1974 Sep; 38(9):763-74. PubMed ID: 4431094
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diagnosis of peripheral circulation disorders using local clearance of Xe-133 in patients with diabetes mellitus].
    Temerinac S; Borota R; Kovacev T
    Med Pregl; 1986; 39(5-6):215-8. PubMed ID: 3796462
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of lumbar sympathectomy on muscle and skin blood flow of the extremities.
    Fernandes FV; Godinho FM
    Bibl Anat; 1973; 11():473-80. PubMed ID: 4789082
    [No Abstract]   [Full Text] [Related]  

  • 39. Muscle blood flow in children, measured by 133Xe clearance method.
    Goetzová J; Skovránek J; Samánek M
    Cor Vasa; 1977; 19(2):161-4. PubMed ID: 332442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The measurement of blood flow through muscle from the clearance of radioactive xenon.
    Bell G; Short DW
    Surg Gynecol Obstet; 1968 Jul; 127(1):61-5. PubMed ID: 5657783
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.